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ABSTRACT
Cancer metastasis is a complex process involving cell-cell interactions mediated by 
cell  adhesive  molecules.  In  this  study  we  determine  the  adhesion  strength  between  an 
endothelial  cell  monolayer and tumor cells of different metastatic potentials using Atomic 
Force Microscopy. We show that the rupture forces of receptor-ligand bonds increase with 
retraction speed and range between 20 and 70 pN. It is shown that the most invasive cell lines 
(T24, J82) form the strongest bonds with endothelial cells. Using ICAM-1 coated substrates 
and a monoclonal antibody specific for ICAM-1, we demonstrate that ICAM-1 serves as a key 
receptor on endothelial cells and that its interactions with ligands expressed by tumor cells are 
correlated with the rupture forces obtained with the most invasive cancer cells (T24, J82). For 
the less invasive cancer cells (RT112), endothelial ICAM-1 does not seem to play any role in 
the  adhesion  process.  Moreover,  a  detailed  analysis  of  the  distribution  of  rupture  forces 
suggests that ICAM-1 interacts preferentially with one ligand on T24 cancer cells and with 
two ligands on J82 cancer cells. Possible counter receptors for these interactions are CD43 
and MUC1, two known ligands for ICAM-1 which are expressed by these cancer cells. 
INTRODUCTION
Adhesive  interactions  of  cancer  cells  with  the  endothelium are  key  events  in  the 
metastasis process (i.e. the dispersion of cancer cells from one organ to other parts of the 
body) [1, 2]. During the formation and growth of tumors, cancer cells manage to escape from 
primary tumors and penetrate the blood flow, thus can travel over long distances. At distant 
sites within the human body, cancer cells interact with the endothelium, adhere and eventually 
extravasate,  i.e.  migrate  through  the  endothelial  barrier.  Leukocytes  and  cancer  cells  use 
similar mechanisms for interacting with endothelial cells (ECs), but while the phenomena of 
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adhesion and migration of leukocytes through the endothelium has been particularly studied 
during  inflammation,  few  results  are  available  regarding  the  role  of  the  key  molecules 
involved in the adhesion and transmigration of cancer cells [1, 3, 4, 5].
Similarly to leukocyte recruitment, tethering and rolling of tumor cells (TCs) on the 
endothelium have been demonstrated for some cancer cells and are mediated by selectins. 
After this  initial  interaction,  firm adhesion takes place,  mediated by several  cell  adhesion 
molecules belonging to the integrin family [6] as well as the Intercellular Adhesion Molecule-
1 (ICAM-1) and Vascular Cell Adhesion Molecule-1 (VCAM-1) from the immunoglobulin 
family,  leading to  tumor invasion  [7,  8].  VCAM-1 is  expressed by the endothelium after 
stimulation,  and  interacts  with  the  α4β1  integrin,  while  ICAM-1  is  expressed  by  ECs, 
leukocytes and some TCs, and can be upregulated by inflammatory cytokines. ICAM-1 is 
involved in leukocyte adhesion to the endothelium through its interactions with LFA-1 and 
Mac-1 leukocyte integrins (β2 integrin). TCs lack  β2 integrins, but neutrophils can act as a 
bridge between TCs and ECs, with LFA-1 on leukocytes binding to ICAM-1 expressed on 
both endothelial and TCs [5]. In addition, ICAM-1 is a receptor for other molecules, such as 
CD43 [9] and MUC1 [10], which are expressed by some TCs. 
Cancer progression is associated with alterations in the expression of some adhesive 
molecules. Some works investigated the relationship between the N-cadherin expression and 
the progression of  tumor  malignancy [11,  12].  An increase of  cancer  cell  invasiveness  is 
combined with switching of E-cadherin by N-cadherin and an increase in the expression of 
some integrin sub-units [13]. From a quantitative point of view, the comparison of adhesive 
properties  in  non-malignant  and  malignant  epithelial  bladder  cells  have  shown  that  an 
enhanced N-cadherin level in T24 malignant cells was accompanied by changes in unbinding 
properties of individual N-cadherin molecules [14]. In addition, the ICAM-1 expression has 
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been associated with a more aggressive tumour phenotype [15, 16]. Nevertheless, the ligands 
involved in the firm adhesion of TC are not yet as clearly defined as for leukocytes, and the 
quantification  of  such  adhesive  interactions  between  ECs  and  cancer  cells  has  not  been 
investigated so far.
Quantitative information on the cell adhesive forces can be obtained using different 
force spectroscopy techniques: the bio-membrane force probe [17], optical tweezers [18] and 
the atomic force microscope (AFM) [19].  All  these techniques operating under an optical 
microscope allow to visualise the cells and simultaneously measure adhesion forces from a 
few pN to a few hundreds pN or more. In this work, we choose to use the single-cell force 
spectroscopy mode of the AFM to study cell-cell interactions involved in the adhesion of TCs 
on ECs. In contrast with other methods of adhesion strength, this technique allows to carry out 
measurements in a configuration close to the in vivo situation. A cancer cell is attached to a 
soft cantilever and put in contact with an EC-monolayer and the force signal is monitored 
thanks to the AFM cantilever deflection [19, 20]. The signal also allows detecting events such 
as possible breakups of receptor-ligand bonds as well as the global adhesion strength at the 
cell level.
Determination  of  cell-cell  interactions  was  carried  out  for  different  cantilever 
retraction  speeds  to  study  how  rupture  force  (involved  in  cell-cell  adhesive  bonds)  is 
modified. We investigated the relationship between the measured receptor-ligand bonds and 
the corresponding metastatic potential of human bladder cancer cells, in order to determine 
the adhesive signature of such cancer cells. Finally, we show that the ICAM-1 receptor on the 
ECs acts as a key mediator for the adhesive interaction with the most invasive cancer cells.  
Our findings indicate that the more invasive bladder cancer cells interact thanks to one or two 
types of ICAM-1 ligands: CD43 and MUC1 are good candidates, as demonstrated by flow 
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cytometry  experiments.  This  knowledge  about  such  interactions  is  essential  for  the 
understanding of cancer cell adhesion to the endothelium, a mechanism leading to invasion 
and metastasis.
MATERIALS AND METHODS
Cells and cell culture
Three  bladder  cell  lines  were  used  in  this  study:  RT112,  T24  and  J82  (ATCC, 
Rockville,  MD).  These cell  lines  represent  progression from well  to  poorly differentiated 
phenotypes and arise from superficial  to invasive epithelial  human bladder cancer.  RT112 
cancer cells are moderately differentiated and are characterized by a cytological grade 2 (or 
differentiation) [21]. T24 and J82 cancer cells are poorly differentiated and characterized by a 
cytological grade 3. To distinguish cancer cells from HUVECs, cancer cells were transfected 
with  a  plasmid  expressing  GFP (Green  Fluorescent  Protein  –  pEGFP).  Human  Vascular 
Umbilical  Endothelial  Cells  (HUVECs)  were  purchased  from  Promocell  (Heidelberg, 
Germany). Cancer cells were grown at 37°C in a humidified 5% CO2 atmosphere, in RPMI 
1640 medium supplemented with 10% fetal calf serum, 100 UI/mL penicillin and 100 µg/mL 
streptomycin (complete RPMI medium). ECs were maintained in Promocell culture medium. 
The ECs were plated in complete culture medium on glass coverslips coated with collagen I 
(BD Biosciences, Le pont de Claix, France) and left 3 days to spread in order to achieve 
confluence.  For  AFM  experiments,  the  culture  medium  was  supplemented  with  HEPES 
(20mM, pH 7.4).
Atomic Force Microscopy
We used a Nanowizard II AFM (JPK Instruments, Berlin, Germany) mounted on a 
Zeiss microscope (Carl Zeiss, Jena, Germany). This configuration allows to carry out AFM 
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measurements  and  simultaneously  observe  the  cells  using  phase  contrast  or  fluorescence 
modes. This AFM is also equipped with the 'CellHesion' module (JPK Instruments, Berlin, 
Germany). This module enables a long-range vertical displacement of the stage up to 100µm 
which makes force spectroscopy measurements possible including cell-cell interactions. In 
parallel,  a  vertical  piezotranslator  (PIFOC,  Physik  Instrumente,  Karlsruhe,  Germany)  is 
mounted on the microscope objective to move the objective concurrently with the microscope 
stage and focus on cells while carrying out AFM measurements. All the measurements were 
carried out at 37°C using the Petri Dish Heater (JPK Instruments, Berlin, Germany).
Cantilever coating
Soft cantilevers were V-shaped ones without tips (MLCT-O, Bruker,  France). They 
were  calibrated  using  the  thermal  fluctuations  analysis  method  [22]  and  exhibit  a  spring 
constant close to 0.01 N/m. To enable the adhesion of cancer cells to the cantilever, the latter 
was functionalized using biotin-conA (Interchim, Montluçon, France) [23]. After rinsing with 
PBS,  cantilevers  were incubated overnight  at  37°C in biotin-BSA (Interchim, Montluçon, 
France)  (0.5 mg/ml),  rinsed  again  in  PBS  and  then  incubated  in  streptavidin  (Interchim, 
Montluçon, France) (0.5mg/ml) for 10 minutes. Finally, cantilevers were rinsed with PBS and 
set into a biotin-conA drop during 10 minutes then rinsed with PBS.  This molecule allows 
binding of cancer cells to the cantilevers with a force larger than the cell-cell detachment 
force in our study: biotin-conA adheres to the cancer cell membrane with a detachment force 
of 2 nN [20], while the detachment force relevant in the interaction between cancer cell and 
EC is on the order of 1 nN. 
Cancer cell capture
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Cancer cells were grown in culture flasks, then were detached just before the AFM 
experiments,  using  a  trypsin/EDTA solution  (0.05% trypsin  and  0.53 mM EDTA).  RPMI 
medium with serum was added to the cells to block the effect of trypsin. Finally, cells were 
centrifuged and resuspended in medium without serum. Cancer cells were deposited in a Petri 
dish onto which an EC monolayer had been grown, and settled for a few seconds. Cell capture 
consisted  in  positioning  the  cantilever  tip  above  a  cancer  cell  (since  cancer  cells  were 
fluorescent, they could be distinguished from ECs, see Figure 1), to come into contact with 
the cell during ten seconds with a force of 1nN. Then the cantilever with the captured cell was 
retracted slowly at constant speed and the cell was kept in culture medium to rest  for 15 
minutes. Next, 1 ml of RPMI 1640 medium with serum was added. The cell was firmly bound 
to the cantilever and subsequently used to probe adhesion to ECs. 
Force spectroscopy: analysis of cancer cell-EC interaction
First, the cancer cell was set above an EC. The cantilever was lowered at constant low 
speed  (1 µm/s)  to  put  the  cancer  cell  in  contact  with  the  EC  (above  the  nucleus).  A 
compression force of 1 nN was applied to the EC during 10 seconds (Figure 1A) in order to 
create bonds and to reproduce firm adhesion. Finally, the cancer cell was retracted with a 
speed ranging between 0.5 µm/s to 20 µm/s. Measurement of the cantilever deflection during 
vertical motion was recorded during the different stages (Figure 1B). Typically, for one cancer 
cell-EC pair, a sequence of five force curves was obtained at five different retraction speeds 
(with a rest time of about 1 minute between each curve). Then the cancer cell was left at rest 
during ten minutes and moved above another EC to measure a sequence of five force curves 
again. Finally, each cancer cell was used three or four times, therefore fifteen or twenty such 
force curves (N = 15 or N = 20) were obtained. The measurements were then collected for 
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various cancer cell lines, during similar experiments. A sketch of the typical retraction force in 
terms of the piezo displacement is presented in Figure 1C. The minimum point on the curve is  
the detachment force, i.e. the force necessary to separate the cancer cell from the EC. The 
detachment force is supported by the cell deformability, but also by the number and strength 
of  adhesive  bonds  formed  between  cells.  The  different  jumps  in  force  correspond to  the 
successive  breakups  of  bonds  involved  during  cell-cell  interaction  [24,  25]  and therefore 
represent  rupture forces  (i.e.  receptor-ligand bonds).  Note that  a  force jump can follow a 
plateau in force, corresponding to tether formation, whose extension is the plateau length. The 
retraction  curve  also  provides  information  about  the  adhesion  energy  which  is  the  work 
necessary to detach the cancer cell (shaded area in Figure 1C). This includes the work done to 
stretch  the  cells  as  well  as  the  work  done to  break  the  molecular  bonds  [25].  All  these 
parameters (detachment force, rupture force, adhesion energy) are obtained from the force 
curve using the Image Processing Software (JPK instrument, Berlin, Germany). For each set 
of conditions, AFM experiments were carried out about 9 times on 3 different days. Unless 
otherwise stated, data are reported as mean ± standard error of the mean. All statistical tests 
were performed using the R software (2.14 release). Since the data are correlated, we used a 
Generalized Linear Mixed Model (GLMM). Differences between the parameters calculated 
on untreated and anti-ICAM-1-treated cells were tested by the mixed function of the afex 
package in R software.  
Inhibition of ICAM-1 ligands on the ECs
Human monoclonal antibody to ICAM-1 [27] was used at a 30 µg/mL concentration. 
Before the AFM experiments,  ECs were incubated for  15 minutes  in  the presence of the 
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antibody at  37°C.  Then cells  were  rinsed twice  in  PBS and incubated in  2 ml of  culture 
medium.
Immobilization of ICAM-1 and BSA
A 20 μL aliquot of recombinant ICAM-1 (RD Systems, Lille, France) (25 μg/ml) in 
0.1  M  NaHCO3 (pH 8.6)  was  adsorbed  overnight  at  4°C  at  the  centre  of  the  coverslip. 
Unbound proteins were removed by washing with PBS and 2 ml of complete RPMI 1640 
medium were then added to the ICAM-1 coated dish before the AFM experiments.
   For the BSA-coating protocol,  a 30 μL aliquot  of  BSA at  100 μg/ml in  PBS was 
adsorbed 30 minutes at 37°C at the centre of the Petri dish. Unbound proteins were removed 
by washing with PBS and 2 ml of the complete RPMI medium were then added to the BSA 
coated dish before the AFM experiments. 
Flow  cytometry  analysis  of  ICAM-1,  MUC1  and  CD43  expression  and 
immunofluorescence staining
Expression levels of ICAM-1 (on the EC surface), MUC1 and CD43 (on the cancer 
cell surface) were analyzed by flow cytometry (Accuri C6 flow cytometer, BD Bio-sciences). 
Quantification  was  made  by  measuring  the  geometric  mean  fluorescence.  For 
immunofluorescence staining, glass coverslips were coated with 25 µg/ml human fibronectin. 
Cells were fixed with 2% paraformaldehyde, and processed for indirect immunofluorescence 
microscopy. 
For measuring expression levels of ICAM-1 and MUC1, ECs or cancer cells  were 
incubated with the primary antibody and then with FITC-conjugated (goat anti-mouse IgG) 
secondary antibody (Jackson ImmunoResearch, USA). The primary antibodies are a Human 
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monoclonal antibody to ICAM-1 [26] or an anti-MUC1 monoclonal antibody C595 (Santa 
Cruz Biotechnology, Santa Cruz, USA). The anti-MUC1 antibody recognizes a tetrapeptide 
motif within the protein core of the MUC1 molecule. 
For CD43 expression level, cancer cells were incubated with a monoclonal antibody 
CD43-clone L10 labeled with FITC (Invitrogen, USA), which reacts with the extracellular 
domain.
RESULTS
Adhesion of different cancer cell lines
To evaluate if cancer cell invasiveness is related to its adhesive properties, we carried 
out  force  spectroscopy  measurements  targeting  the  interaction  between  cancer  cells  (of 
different invasiveness) and ECs. The cancer cells arise from the following cell lines: RT112, 
T24 and J82. RT112 cells are the less invasive cells while T24 and J82 cells are the more 
invasive  ones  [21].  Force  curves  were  performed  between  a  cancer  cell  attached  to  the 
cantilever tip and a monolayer of ECs plated on a glass coverslip. Figure 2 shows typical 
force curves obtained during the interactions of the three cancer cell  types (T24, J82 and 
RT112) with the ECs. Each retraction curve (retraction velocity V = 5µm/s) shows several 
rupture events  associated  with the  successive breaking of  bonds involved during cell-cell 
interaction. Interestingly, the less invasive cells (RT112) present smaller rupture force steps as 
compared to most invasive cells (T24, J82). Moreover,  the detachment force which is the 
minimum point (Figures 2A-B-C) of the curve is smaller for RT112 cells. Figures 2A-B-C 
also show the distribution of rupture forces detected for cancer cell interactions with ECs at 
V = 5 µm/s. These magnitudes [10-70 pN] are in the range of typical force values obtained for 
receptor-ligand  bonds  [23,  27,  28,  29].  It  is  noteworthy  that  the  three  cell  types  exhibit 
different force values: measurements reveal an average rupture force of 29.6 ± 0.8 pN for 
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RT112, 34.0 ± 0.9 pN for T24 and 44.2 ± 1.1 pN for J82 (V = 5 µm/s). Note that the average 
rupture forces are smaller for RT112 cells which are the less invasive kind.
Adhesion energy and detachment force (cell level)
An important  aspect  to  characterize  the  interaction  of  cancer  cells  to  ECs  is  the 
adhesion energy which involves the whole cell contact area. The adhesion energy is derived 
through integration of the area below the curve F(z), where F is the force and z is the piezo 
displacement. The basis line is chosen as the final limiting value, after all bonds are detached. 
The JPK software allows to choose this value and then performs the integration. Therefore 
we investigated the adhesion energy as well as the detachment force (absolute value of the 
minimum force on retracting force curve,  see Figure 1B) versus retraction speed (V).  As 
shown  in  Figure  3,  these  two  parameters  increase  with  retraction  speed.  Regarding  the 
adhesion energy, the most invasive J82 cells present larger values as compared to the T24 or 
RT112 cells. Moreover, this difference is confirmed by the detachment force values which are 
higher for J82 cells as compared to T24 and RT112 cells. In any case, detachment forces or 
adhesion energies are always smaller with the less invasive RT112 cell.
Effect of retraction speed on rupture force
The rupture force has been shown theoretically  to  depend on the logarithm of the 
loading rate of the cantilever [30]. To study the signature of each cancer cell line, one needs to 
analyze the force spectra  of the three cancer  cell  types  during their  interaction with ECs 
(Figure 4).  These  spectra  present  force  values  depending  on  the  retraction  speed  or 
equivalently the loading rate rf (N/s), equal to the product of the retraction speed V (m/s) 
times  the  spring  constant  k  (N/m)  of  the  cantilever,  i.e.  rf  =  kV.  Force  values  increase 
- 11 -
gradually with retraction speed and vary between 20.8 ± 0.7 pN and 47.4 ± 1.9 pN for RT112 
cells, between 27.1 ± 1.1 pN and 52.4 ± 2.0 pN for T24 cells, and between 31.6 ± 1.0 pN and 
65.8 ± 1.6 pN for J82 cells. For the three cancer cell lines, the average rupture force versus the 
logarithm of the retraction speed increases, but is not linear. 
Measurement of specific and non specific adhesion forces for cancer cells
In a previous study, we showed that ICAM-1 was involved in TC extravasation [4]. To 
test the specific adhesion between cancer cells and ICAM-1 molecules, we carried out force 
spectroscopy experiments between a cancer cell attached to the tip of an AFM cantilever and 
immobilized ICAM-1 molecules on a glass dish. As shown in Figure 5, these measurements 
reveal  that  rupture  forces  are  very  close  to  the  ones  already obtained for  cancer  cell-EC 
interaction [28]. The values are in the range of [20-70pN] for a retraction speed between 
0.5 µm/s and 20 µm/s. To compare these values to the non specific adhesion forces, we also 
measured the rupture forces between TCs and a BSA-coated surface. The force level involved 
in  the non specific  adhesion is  in  the range of  [10-45pN] which is  much less  important, 
around 40% to 70% of the specific binding force.
Role of the ICAM-1 receptor
As shown by confocal microscopy imaging (Figure 6A), the expression of ICAM-1 on 
unstimulated ECs is moderate. FACS analysis (Figure 6B) confirms the ICAM-1 expression 
level, when comparing the fluorescence levels of cells treated with an irrelevant antibody and 
with  the  anti-ICAM-1  antibody.  To  determine  the  relative  contribution  of  the  ICAM-1 
receptor  on  cell-cell  adhesion,  we  examined  the  alteration  of  the  adhesion  forces  when 
blocking this receptor with a specific monoclonal antibody. Figure 7 shows the effect of the 
antibody against ICAM-1 during the adhesion of the three cancer cell types with the ECs. 
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Interestingly, inhibition of the EC ICAM-1 resulted in a significant decrease of the rupture 
forces for the more invasive cells only. For T24 cells, force averages varied between 27.1 pN 
and 52.4 pN (at  different  velocities)  without  blocking  the  ICAM-1 receptor,  but  between 
14.4 pN and 35.7 pN, when blocking ICAM-1 (Figure 7A). This effect is also clearly visible 
on the box-whisker-plot  obtained at a retraction speed of 5 µm/s (Figure 7 B).  The anti-
ICAM-1 antibody induces a significant decrease of the rupture force for T24 (from 34pN to 
21.8  pN,  see  Figure  7B)  and the  value  of  21.8  pN (+/-  0.7)  obtained after  using  of  the 
antibody is comparable to the rupture force value of 23.3pN (+/- 1.6) obtained for T24-BSA 
adhesion (see figure 7G). Therefore, after inhibition of ICAM-1, the rupture force level is  
typical of a non specific adhesion. This inhibition seems to be practically complete for T24 
cells.  For  J82  cells,  force  averages  vary  between  31.6 pN and  65.8 pN without  blocking 
ICAM-1 and between 17.7 pN and 58.1 pN when blocking ICAM-1.  This  effect  of  anti-
ICAM-1 is clearly visible in the box-whisker plot of Figure 7D: the mean value decreases 
from 44.2 pN to 30.4 pN at a retraction speed of 5 µm/s. Finally, the adhesion of RT112 cells 
to ECs is not decreased in the presence of the anti-ICAM-1 antibody: the average values vary 
between 20.8 pN and 47.4 pN whereas they are between 21.1 pN and 58.6 pN when blocking 
ICAM-1. This non significant effect of the anti-ICAM-1 antibody is confirmed by the box-
whisker plots (Figure 7F): the antibody does not induce any decrease in the rupture force. 
Therefore, an important reduction in binding forces for invasive cells (e.g. 35% for J82 and 
T24 cells) has been quantified here whatever the velocity, whereas there is no change in the 
case of the less invasive RT112 cell. This demonstrates clearly that ICAM-1 expressed by ECs 
plays a crucial role on the firm adhesion of the more invasive cells (J82 and T24). 
Detailed analysis of rupture forces
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Since we used average values of rupture forces which may hide the complexity of the 
adhesive bonds, a more detailed inspection of the force jumps (as shown using histograms) 
was carried out in order to gain more information. This analysis is given in Figure 8 where the 
TC-ECs or the TC-substrate (ICAM-1 or BSA) force jumps are recorded and presented using 
histograms, at a given velocity of 5 µm/s. Inspection of the histogram of T24-ECs rupture 
forces  in  Figure  8A (without  the  effect  of  anti-ICAM-1)  reveals  a  Gaussian  distribution 
centered  at  32.9  pN (+/-  5.8).  Interestingly,  this  distribution  of  forces  found for  T24-EC 
interaction is quite similar to the one obtained during the interaction between T24 and the 
ICAM-1 coated-substrate (i.e. mean value = 28.8 pN +/- 5.1) (see histogram in Figure 8D). 
On the other hand, when the ECs have been treated with the anti-ICAM-1 antibody, the peak 
in Figure 8A almost disappears (the area under the curve is divided by a factor of ten). A new 
peak centered at 19 pN appears, similar to the value of 21.5 pN found for T24 interacting with 
the BSA-coated surface (Figure 8E) which can be attributed to non-specific interactions.
 The histogram of J82-EC rupture forces reveals a distribution of a double Gaussian 
distribution : there are two peaks initially (42 pN and 70 pN) as can be seen by the large 
spectrum of force values. After incubation with the antibody, the last peak (70 pN) completely 
disappears whereas the first one (42 pN) is lowered by a factor of 3 (Figure 8B). We may 
conclude that ICAM-1 is expected to interact with two ligands on the J82 cell surface, and 
that  the  antibody inhibits  both  interactions,  but  preferentially  one.  These  bonds  could  be 
specific interactions with two different ligands for instance. In addition (Figure 8B), a new 
lower peak appears when using the antibody (≈ 28pN), whose value is very close to the one 
found for non-specific bonds.
The case of RT112 cell is different, as can be seen in Figure 8C. There is only one 
peak with and without the antibody located at similar levels (28 pN and 33 pN, no significant 
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difference).  The  addition  of  anti-ICAM-1  antibody  does  not  change  the  overall  curve, 
therefore no clear effect is detected for RT112 cells, indicating that ICAM-1 is probably not 
involved in this adhesion process. 
Analysis of ICAM-1 ligands (CD43 and MUC1) expression by invasive cells T24 and J82
Bladder cancer cells do not express the common ICAM-1 ligands, such as LFA-1 or 
Mac-1 [5]. On the other hand, the expression of MUC1 (Mucin 1) and CD43 (Leukosialin) 
were recently described as ICAM-1 ligands [31, 10, 9, 32]. Therefore, we quantified their 
expression by flow cytometry. The results in Figure 9 show that T24 cells express only the 
CD43 ligand while J82 cells express both CD 43 and MUC1 ligands. Concerning RT112 cells, 
they express only the CD43 ligand. These results are discussed below.
DISCUSSION
The mechanisms by which cells interact with the endothelium have been investigated 
in great details for leukocytes [20, 33]. Experiments using AFM have proven to be very useful 
for  studying these  interactions  allowing to  quantify  the  adhesive  forces  between a  single 
leukocyte  and  an  endothelial  monolayer.  Moreover,  this  technique  helps  to  identify  the 
molecules  involved  in  the  adhesion  between  cancer  cells  and  the  endothelium.  Such 
experiments involving receptor-ligand bonds have been carried out by Zhang et al. [20, 25] 
using leukocytes in contact with ECs to investigate the role of VCAM-1, ICAM-1, selectins, 
β1 and  β3 integrins. A qualitative study on cancer cell-EC interactions using AFM was also 
made  by  Puech  et  al.  [24]  but  they  showed  no  detailed  analysis  about  these  kinds  of 
interactions.  Therefore,  this  work  focuses  on  the  possible  adhesion  molecules  and  forces 
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involved  during  interactions  between  bladder  cancer  cells  (T24,  J82  and  RT112)  and  an 
endothelial monolayer. 
The method used here is similar to previous works [19, 29, 24], since we catch cancer 
cells  with the cantilever and lower it  to  make contact  with the ECs. Then we retract the 
cantilever, to capture the signature of receptor-ligand bonds from the force signals, as shown 
schematically  in  Figure  1  and  in  real  experiments  (Figure  2).  One  question  here  is  to 
determine whether  such receptor-ligand bonds involve  ICAM-1 when long tethers  appear 
(Figure 1). Indeed Helenius et al. [28] showed that tethers usually correspond to the final part 
of the force curve, i.e. at long distances. Carpén et al. [34], on the other hand, showed possible 
connections  of  ICAM-1  to  the  cytoskeleton,  suggesting  the  presence  of  bonds  at  shorter 
distances. In fact, this question still remains open as shown recently [35] since ICAM-1 can 
be found in filipodia, both on endothelial cells and on cells transfected with ICAM-1. This 
means  that  it  is  possible  that  tethers  present  ICAM-1 with  or  without  any link  with  the 
cytoskeleton, and break far from the contact region, i.e. at large distances. Furthermore, it is 
possible that tethers may form on the cancer cell side. Finally, one may also consider the 
Jurkat cell-endothelial cell case [20] where the formation of long tethers and high adhesion 
energies  is  attributed  to  the  presence  of  adhesion  molecules  such as  ICAM-1,  which  are 
inhibited by antibodies (around 40% inhibition for the anti-ICAM-1 antibody). Thus it will be 
considered here that most receptor-ligand bonds arise from the presence of ICAM-1.
In our experiments, values of the adhesion energies are exhibited (Figure 3) for the two cell 
lines RT112 and T24, very similar to other studies [20, 25, 36]. On the other hand, J82 cells 
show higher values (≥ 4.0 10-15J) than the ones usually measured. This could be linked to the 
fact that they form two types of receptor-ligand bonds (Figures 8-9), as will be discussed 
below. In addition, the detachment force increases with the retraction speed and is larger for 
- 16 -
the more invasive cells. This result shows that adhesion at the cell level is higher for the more 
invasive cells and does not depend on retraction speed. As mentioned in the literature, we may 
assume that these higher detachment  forces obtained with the more invasive cells in AFM 
stretching experiments are associated with higher cell stiffness [37]. Indeed, complementary 
elasticity  measurements  (data  not  shown) on the  cell  body using  a  spherical  AFM probe 
confirm that the more invasive cells are more rigid (elastic modulus E = 493 ± 138 Pa for J82 
cells, 351 ± 90 Pa for T24 cells and 246 ± 95 Pa for RT112 cells). But, as was discussed 
before, the contribution of adhesive events (breaking of receptor-ligand bonds) also plays a 
role in the global cell response.
Different levels of rupture forces are obtained (Figure 4), ranging between 20 and 70 
pN. These values are similar to those previously obtained in other studies [28] for different 
types of receptor-ligand bonds like cadherin-cadherin [38, 14], integrin-immunoglobulin [25, 
39] or selectin-mediated bonds [40]. It clearly appears that the cells with the higher metastatic 
capacity show higher rupture force levels. This difference in adhesion strength for the three 
cancer  cell  lines  studied is  valid  whatever  the retraction speed [0.5-20 µm/s].  These data 
suggest  that  for  different  types  of  cancer  cells,  either  various  receptor-ligand  pairs  are 
involved or these pairs are regulated differently with more or less affinity [41].
To shed light into these mechanisms, we investigated the distribution of rupture forces 
at  different retraction speeds (i.e.  different  loading rates),  which exhibits  multiple loading 
regimes, as seen by a continuous curve in the f-log(V) diagram (Figure 4). This behavior can 
be compared with the force-spectroscopy results obtained for leukocytes (expressing LFA-1) 
attached to substrates coated with ICAM-1 or ICAM-2 [42]. The meaning of the non-linear 
increase in rupture forces with retraction speed is related to the initial Bell's model [30] and its 
extensions by Evans and Richtie [43]. This theory predicts three different regimes of rupture 
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force f vs. log(rf). In the first regime, f increases slowly; then at intermediate velocities, the 
force increases linearly vs log(rf) then we move into ultrafast regimes. Typically AFM data at 
classical velocities lie in the transition between the first two regimes where dependence is 
non-linear  and  increases  monotonically.  Only  measurements  on  model  systems  (like 
streptavidin-biotin  for  example)  exhibit  a  linear  dependence.  Usually  with other  receptor-
ligand bonds, the response is always non-linear, and is more complex due to possible effects 
due to multiple types of bonds,  leading to multiple barriers in the energy landscape [42].  
Therefore  the  ICAM-1  receptor/ligand  system  presently  characterized  possibly  involves 
multiple receptor-ligand types.
As shown by the values of the force jumps which are in the range [20pN-70pN], it 
appears that specific receptor-ligand bonds are present [28]. These interactions could involve 
endothelial adhesion molecules such as ICAM-1, VCAM-1 and E-selectin which have been 
shown to play an important role for the interactions between cancer cells and the endothelium 
monolayer [4, 7]. Previously, we identified the role of ICAM-1 for cancer cell adhesion to the 
endothelium [4]; therefore, we investigated here the role of ICAM-1 expressed on ECs on 
these adhesion mechanisms by using a specific anti-ICAM-1 antibody (Figure 6). The use of 
anti-ICAM-1 led to a significant reduction of the rupture forces for the more invasive cells 
(reduction of 35% on average for T24 and J82 cells) but no significant inhibition was found 
for the less invasive RT112 cells (Figure 7A to 7E). This result confirms the implication of 
ICAM-1 in  the  adherence  of  T24 and  J82 cancer  cells  to  ECs.  The  rupture  force  levels 
obtained for T24 cells when the ICAM-1 antibody is used (Figure 7A and 7B) are mostly in 
the range [15-40pN] for increasing retraction speed, a low value probably corresponding to 
non-specific bonds. This is indeed confirmed by force spectroscopy experiments with BSA-
coated substrates, giving similar numbers (Figure 5 and Figure 7G). On the other hand, the 
- 18 -
levels  of  forces  obtained between T24 cells  and an  ICAM-1 coated  surface  are  identical 
(within  experimental  error)  to  the  rupture  forces  measured  during  T24-ECs  interactions, 
confirming the presence of an interaction with ICAM-1.
Finally, to understand the details of these interactions, we analysed the rupture force 
distributions at a given retraction speed (5µm/s) through histograms and box-whisker plots as 
presented in Figure 8. First,  this analysis is consistent with the previous results. The anti-
ICAM-1 suppresses the specific interactions only for the more invasive cells: (i) the peak 
around 32.9 pN for T24 cells disappears when using the anti-ICAM-1 antibody (see Figure 
8A) (ii) the high peak (70 pN) found for J82 cells completely disappears and the second one 
(42pN) is lowered by a factor 3 when using the antibody (see Figure 8B). Notably, the T24 
cells and the J82 cells do not show the same number of peaks: this suggests that the ICAM-1 
receptor on the EC interacts with one ligand on T24 cells and with 2 ligands on J82 cells.  
 Concerning  the  molecular  structure  linking  cancer  cells  to  the  endothelium,  since 
bladder  cancer  cells  do  not  express  common ICAM-1 ligands,  such as  LFA-1 or  Mac-1, 
possible ligands on the cancer cell could very well be the MUC1 or CD43 ligands [31, 32, 
44]. Geng  et al. [44] demonstrated that efficient binding is possible between ICAM-1 and 
MUC1  whose  expression  increases  with  the  invasivity  of  breast  cancer  cells  [31].  Our 
measurements using flow cytometry demonstrated clearly that T24 cells express only MUC1 
whereas  J82  cells  express  MUC1 and  CD43 (Figure  9).  These  results  are  in  very  close 
connection with the histogram analyses presented above, suggesting the presence of at least 
two ICAM-1 ligands on J82 cells and only one ligand on T24 cells. Note that for RT112 cells 
expressing only CD43, the endothelial ICAM-1 receptor does not seem to be involved, as 
shown by AFM spectroscopy.
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To conclude, these experiments reveal the involvement of the endothelial ICAM-1 in 
the interactions between T24 and J82 TCs and ECs. The possible ICAM-1 ligands involved in 
this interaction are CD43 for T24 cells and both MUC1 and CD43 for J82 cells. Additional 
experiments are under way for studying the precise role of these two ICAM-1 ligands on these 
interactions.  On the  other  hand,  the  less  invasive  RT112 cell  does  not  adhere  using  this 
molecular scenario. This study provides a straightforward perspective for the understanding of 
the molecular mechanisms of the cancer cell-endothelium interactions. It leads to significant 
differences  between  cells  of  various  metastatic  potential  and  could  provide  interesting 
therapeutic means to block the extravasation process.
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FIGURE LEGENDS
Figure 1. Interactions between cancer cells and ECs measured with AFM
 A) Photograph of the cantilever with attached fluorescent cancer cell  above the HUVEC 
monolayer.  White  scale  bar  corresponds  to  20  µm.  B) Sketch  of  the  approach-retraction 
method and typical retraction force curve in terms of the piezo displacement. The cancer cell 
approaches the EC monolayer at constant speed. Then the cell comes into contact with the EC 
during  10 seconds  (under  1nN applied  force)  to  create  several  bond complexes  over  the 
adhesion area. The cantilever is retracted at constant velocity in order to detach the adhesive 
bonds.  The  retraction  curve  shows force  jumps  corresponding to  the  rupture  force  (f)  of 
bonds.  The  adhesive  energy  (shaded  area)  represents  the  detachment  work  done  by  the 
cantilever to completely detach the cell from the substrate. The detachment force is the force 
necessary to stretch the cancer cell and the EC until bonds start to detach. Note that some 
force jumps can follow a plateau corresponding to tether formation.
Figure 2. AFM force curves and rupture force histograms for different cancer cell lines
Typical force curves after 10s-contact between a TC and an EC on a HUVEC monolayer.  
Probability histograms with collected rupture forces f for J82 (A), T24 (B) and RT112 cells 
(C) at V = 5µm/s. Vertical arrows denote examples of force jumps corresponding to breakup 
of receptor-ligand bonds.
Figure 3. Adhesion energies and detachment forces for different cancer cell lines 
Plot  of the adhesion energy (A) and detachment force (B) vs.  retraction speed after  10s-
contact between a TC and an EC on a HUVEC monolayer. Three cancer cell lines: T24 (open 
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circle), J82 (full circle) and RT112 (open square). Data are plotted as mean ± standard error of 
the mean. The line is just a guide for the eye.
Figure 4. Rupture force vs. retraction velocity for different cancer cell lines 
Relationship between rupture force and retraction speed after 10s-contact between a TC and 
an EC on a HUVEC monolayer. Three cancer cell lines: T24 (open circle), J82 (full circle) 
and  RT112  (open  square)  interacting  with  the  endothelium.  Data  are  plotted  as  mean  ± 
standard error of the mean. The line is just a guide for the eye.
Figure 5. Control experiments for T24 cells interacting with recombinant ICAM-1 or 
BSA coated surfaces
Rupture force vs. retraction speed for T24 cells interacting either with a coated substrate or 
with ECs (square).  The substrate  is  coated with BSA 100µg/ml (triangle)  or  recombinant 
ICAM-1 25µg/ml (diamond). Data are plotted as mean ± standard error of the mean. The line 
is just a guide for the eye.
Figure 6. ICAM-1 expression on ECs
A) Confocal microscopy image of an EC monolayer stained for ICAM-1 (green). HUVECs 
were fixed with PFA. Nuclei are stained in blue using DAPI.  B) Quantification of ICAM-1 
levels by FACS analysis (dashed line) in comparison with an irrelevant antibody (solid line). 
Figure 7. ICAM-1 is involved in the interaction between cancer cells and ECs 
Rupture force vs. retraction speed after interaction between cancer cell and an EC, treated 
with an anti ICAM-1 antibody or not. Corresponding box-whisker plots show rupture forces 
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at a retraction speed of 5 µm/s. (A, B) T24-EC, (C, D) J82-EC and (E, F) RT112-EC. As a  
comparison, the rupture force box plot is also shown for the T24-BSA interaction (panel G). 
For panels A, C and E, the line is just a guide for the eye. Data are plotted as mean ± standard 
error  of  the  mean.  Stars  represent  the  p-value  from  GLMM  statistical  tests  between 
parameters calculated on untreated and anti-ICAM-1-treated cells (*p ≤ 0.05).
Figure 8. Distribution of rupture forces and effect of an anti-ICAM-1 antibody
Effect of an anti-ICAM-1 antibody on cancer-EC interactions. Rupture force distributions are 
Gaussian  with  one  or  two  peaks  revealing  the  presence  of  receptor/ligand  bonds  or  non 
specific  interactions. Probability  histograms  of  rupture  force  (V=5  µm/s)  for  (A)  T24-
HUVEC,  (B)  J82-HUVEC,  (C)  RT112-HUVEC.  Black  histograms  represent  interaction 
cancer-cell and EC without antibody whereas red ones show the force distribution after using 
the antibody. Panels D (T24-ICAM-1) and E (T24-BSA) show the rupture force probabilities 
for T24 cells in contact with coated substrates. The number N of events is indicated on the 
histograms. 
Figure 9. Expression of CD43 and MUC1 by the three bladder cell lines used in this 
study
Expression levels of CD43 and MUC1 (red line) by FACS analysis in comparison with an 
irrelevant antibody (black line): (A, D) T24 cells, (B, E) J82 cells and (C, F) RT112 cells.
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